The 20-year cumulative incidence of keratinocyte carcinoma was 1.5% in those who survived childhood cancer, with most patients having several lesions.
Artelo Biosciences Inc. has presented data on its fatty acid-binding protein 5 (FABP5) inhibitor ART-26.12 from testing of its efficacy in preclinical models of psoriasis.
This study reveals hepcidin's significant role in psoriasis, linking iron retention to inflammation and keratinocyte growth, ...